TARA
Protara Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.02 / 10
Netural
Evaluation yields 4.0/10, reflecting moderate financial health. Key positives: Profit-MV and Net income-Revenue, though challenges appear in Revenue-MV and Gross profit margin (%). This configuration appears defensive.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score1/3
Weight9.24%
1M Return5.63%
Value-0.26
Score1/3
Weight9.24%
1M Return5.63%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.27%
1M Return0.22%
Value36.70
Score1/3
Weight0.27%
1M Return0.22%
Net income-Revenue
Value-0.15
Score2/3
Weight13.12%
1M Return8.04%
Value-0.15
Score2/3
Weight13.12%
1M Return8.04%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.29%
1M Return1.75%
Value1.78
Score2/3
Weight2.29%
1M Return1.75%
Asset-MV
Value-0.51
Score3/3
Weight26.98%
1M Return14.63%
Value-0.51
Score3/3
Weight26.98%
1M Return14.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight8.47%
1M Return5.89%
Value47.88
Score3/3
Weight8.47%
1M Return5.89%
Profit-MV
Value0.47
Score2/3
Weight12.94%
1M Return7.95%
Value0.47
Score2/3
Weight12.94%
1M Return7.95%
PB-ROE
Value0.06
Score1/3
Weight11.91%
1M Return6.78%
Value0.06
Score1/3
Weight11.91%
1M Return6.78%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight1.96%
1M Return1.53%
Value7993.84
Score3/3
Weight1.96%
1M Return1.53%
Cash-MV
Value-0.07
Score2/3
Weight12.82%
1M Return7.78%
Value-0.07
Score2/3
Weight12.82%
1M Return7.78%
Revenue-MV
Value-0.26
Score1/3
Weight9.24%
1M Return5.63%
Value-0.26
Score1/3
Weight9.24%
1M Return5.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight8.47%
1M Return5.89%
Value47.88
Score3/3
Weight8.47%
1M Return5.89%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.27%
1M Return0.22%
Value36.70
Score1/3
Weight0.27%
1M Return0.22%
Profit-MV
Value0.47
Score2/3
Weight12.94%
1M Return7.95%
Value0.47
Score2/3
Weight12.94%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight13.12%
1M Return8.04%
Value-0.15
Score2/3
Weight13.12%
1M Return8.04%
PB-ROE
Value0.06
Score1/3
Weight11.91%
1M Return6.78%
Value0.06
Score1/3
Weight11.91%
1M Return6.78%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.29%
1M Return1.75%
Value1.78
Score2/3
Weight2.29%
1M Return1.75%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight1.96%
1M Return1.53%
Value7993.84
Score3/3
Weight1.96%
1M Return1.53%
Asset-MV
Value-0.51
Score3/3
Weight26.98%
1M Return14.63%
Value-0.51
Score3/3
Weight26.98%
1M Return14.63%
Cash-MV
Value-0.07
Score2/3
Weight12.82%
1M Return7.78%
Value-0.07
Score2/3
Weight12.82%
1M Return7.78%
Is TARA undervalued or overvalued?
- TARA scores 4.02/10 on fundamentals and holds a Fair valuation at present. Backed by its -26.81% ROE, 0.00% net margin, -6.74 P/E ratio, 2.69 P/B ratio, and 47.35% earnings growth, these metrics solidify its Netural investment rating.
